{
    "clinical_study": {
        "@rank": "168286", 
        "brief_summary": {
            "textblock": "The purpose of this study to determine the effectiveness of sugammadex in septoplasty\n      patients whose mask ventilation would be difficult after extubation."
        }, 
        "brief_title": "Sugammadex Versus Neostigmine Use in Patients Undergoing Septoplasty Operations", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Nasal Septum Deviation", 
        "condition_browse": {
            "mesh_term": "Nose Deformities, Acquired"
        }, 
        "detailed_description": {
            "textblock": "Patients undergoing septoplasty operation will be included to this study. After coming to\n      operation room all the patients will have standard monitorisation and induction. After\n      intubation they will have inhalational anesthesia as maintenance. According to the TOF\n      (train of  four) measurement all patient will have neuromuscular relaxant if needed. After\n      the operation they will be extubated according to TOF or clinical parameters. And time for\n      extubation, mask assistance need, any complication, mask difficulty, and time spent in\n      postoperative care unit will be recorded. Then the results will be compared, whether\n      sugammadex or neostigmine is better for these patients in means of extubation and\n      postoperative status."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        ASA (American Society of Anesthesiologist) I-II patients undergoing septoplasty operation\n\n        Exclusion Criteria:\n\n          -  patient refusal\n\n          -  any allergy to any medication used"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "patients undergoing septoplasty operation"
            }
        }, 
        "enrollment": {
            "#text": "88", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02026999", 
            "org_study_id": "17393"
        }, 
        "intervention_browse": {
            "mesh_term": "Neostigmine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 1, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ankara", 
                    "country": "Turkey", 
                    "zip": "06550"
                }, 
                "name": "Ankara University"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "1", 
        "official_title": "Phase IV Study of the Use of Sugammadex Versus Neostigmine in Septoplasty Operations", 
        "overall_official": {
            "affiliation": "ANKARA UNIVERSITY FACULTY OF MEDICINE", 
            "last_name": "CIGDEM YILDIRIM GUCLU, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Turkey: Ethics Committee", 
                "Turkey: Ministry of Health"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "easy mask ventilation for septoplasty patients", 
            "safety_issue": "Yes", 
            "time_frame": "time between end of surgery and extubation of the patient, approximately 5 to 10 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02026999"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ankara University", 
            "investigator_full_name": "CIGDEM YILDIRIM GUCLU", 
            "investigator_title": "anesthesiologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Quick and safe transfer from postoperative care unit", 
            "safety_issue": "Yes", 
            "time_frame": "time spent in postanesthesia care unit approximately 10 to 60 minutes"
        }, 
        "source": "Ankara University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ankara University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Day", 
        "verification_date": "January 2014"
    }
}